These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4009446)

  • 21. [Microsomal oxidative metabolism in the liver of rats treated with vinorelbine: evaluation through antipyrine elimination].
    Montenegro-Alvarez P; González-Alfonso M; Cantarino-Aragón MH; Gutiérrez-Ortega C; Guijarro-Escribano FJ
    Gastroenterol Hepatol; 2006 Apr; 29(4):224-30. PubMed ID: 16584692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
    Van Geel CA; Van Bezooijen CF
    Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of amphotericin B treatment duration of hepatic microsomal enzyme function in rats.
    Inselmann G; Voss V; Kunigk F; Heidemann H
    Pharmacology; 1997 Aug; 55(2):87-94. PubMed ID: 9323308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the immunomodulator tilorone on antipyrine disposition in the rat.
    Svensson CK
    J Pharm Sci; 1986 Oct; 75(10):946-8. PubMed ID: 3795024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
    Boobis AR; Brodie MJ; Kahn GC; Toverud EL; Blair IA; Murray S; Davies DS
    Br J Clin Pharmacol; 1981 Dec; 12(6):771-7. PubMed ID: 7340879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsomal enzyme induction by permethrin in rats.
    Anadon A; Diez MJ; Sierra M; Sanchez JA; Teran MT
    Vet Hum Toxicol; 1988 Aug; 30(4):309-12. PubMed ID: 2902710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monthly variations in the clearance of antipyrine in the rat.
    Bélanger PM; Doré F; Labrecque G
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of moderate fluosol-DA hemodilution on gender specific metabolism of antipyrine.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):455-62. PubMed ID: 2781142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of water deprivation on aspirin disposition kinetics.
    Bakar SK; Niazi S
    J Pharm Sci; 1983 Sep; 72(9):1030-4. PubMed ID: 6631688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of primaquine stereoisomers and metabolites on drug metabolism in the isolated perfused rat liver and in vitro rat liver microsomes.
    Mihaly GW; Ward SA; Nicholl DD; Edwards G; Breckenridge AM
    Biochem Pharmacol; 1985 Feb; 34(3):331-6. PubMed ID: 3970715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of cigarette smoke on antipyrine metabolite formation in rats.
    Nakagawa A; Chiba K; Ishizaki T; Nakamura K
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of some benzimidazoles on the disposition of antipyrine and tolbutamide from the rat isolated perfused liver.
    Ward SA; Mihaly GW; Tjia JF; Back DJ
    J Pharm Pharmacol; 1985 Jan; 37(1):62-4. PubMed ID: 2858532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lead intoxication: effects on cytochrome P-450-mediated hepatic oxidations.
    Alvares AP; Fischbein A; Sassa S; Anderson KE; Kappas A
    Clin Pharmacol Ther; 1976 Feb; 19(2):183-90. PubMed ID: 1261156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.